Condition
Acute Myeloid Leukemia (AML) in Remission clinical trials and research
Research outlook What's coming for Acute myeloid leukemia: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 4 Acute Myeloid Leukemia (AML) in Remission clinical trials that are recruiting, at sites in 13 countries (most in Belgium (1), Denmark (1), Finland (1)). By phase: Phase 3 (2), Phase 2/3 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 13Countries
Newest Acute Myeloid Leukemia (AML) in Remission clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Comparing two treatment regimens for children with Acute Myeloid Leukemia undergoing stem cell transplantation | Phase 3 | Brussels and 16 other locations | Recruiting | Jul 28, 2022 |
| Combining azacitidine and venetoclax for maintenance therapy in younger adults with AML in remission | Phase 2/3 | Suzhou, Jiangsu and 1 other locations | Recruiting | Jun 3, 2022 |
| Using CPX-351 to prevent relapse in patients with Acute Myeloid Leukemia in remission | Phase 1/2 | Washington D.C., District of Columbia and 2 other locations | Recruiting | Aug 4, 2021 |
| Comparing two methods to prevent GVHD in leukemia patients after transplant | Phase 3 | Riyadh | Recruiting | Mar 19, 2020 |
All recruiting trials (4)
-
Comparing two treatment regimens for children with Acute Myeloid Leukemia undergoing stem cell transplantation
This study is testing two different treatment plans for children with Acute Myeloid Leukemia who are getting stem cell transplants to see which one helps them survive better and have fewer serious side effects.
-
Combining azacitidine and venetoclax for maintenance therapy in younger adults with AML in remission
This study is testing if combining two medications, azacitidine and venetoclax, can help younger adults with acute myeloid leukemia stay in remission longer after their initial treatment.
-
Using CPX-351 to prevent relapse in patients with Acute Myeloid Leukemia in remission
This study tests if a new treatment called CPX-351 can help people with Acute Myeloid Leukemia who are in remission stay cancer-free longer.
-
Comparing two methods to prevent GVHD in leukemia patients after transplant
This study is testing whether a new method using cyclophosphamide can better prevent graft-versus-host disease in leukemia patients after they receive a stem cell transplant compared to the usual treatment.
Related topics
Quick answers
How many Acute Myeloid Leukemia (AML) in Remission clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 13 countries. The most sites are in Belgium (1 trial), Denmark (1 trial), Finland (1 trial), Hong Kong (1 trial), Israel (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 2/3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.